Now Enrolling in Seattle
Tixel i Clinical Study
Do You Suffer From Dry Eyes?
Dry eye symptoms can include an uncomfortable dry or gritty sensation, excessive tearing, red or irritated eyes, and trouble with screens or contact lenses. If this sounds familiar, you may be eligible to participate.
A New Approach to Treating Dry Eye
Tixel i is a new dry eye technology that uses heat and pressure in a special way that rejuvenates the meibomian glands. Treatments take only a few minutes and are well tolerated. Most people return to their daily routine right after their appointments. Many patients become less dependent on daily therapies like eye drops and lid scrubs.
Cannon EyeCare is enrolling patients in a clinical study of Tixel i, a new technology approved by the FDA to treat Dry Eye Disease (DED) caused by Meibomian Gland Dysfunction (MGD). If you’ve been dealing with chronic dry eye symptoms, this study is an opportunity to try a new therapy that targets the underlying causes of evaporative dry eye.
All patients enrolled in the study will receive the 3 Tixel i treatments at a significant discount. The treatments must be initiated by September 25th, 2025, and are spaced 2 weeks apart. 1-month and 3-month follow-ups will be required. Patients will be asked to do 6 and 12-month follow-ups as well so that we can measure the long-term benefits of Tixel treatment for dry eye.
Wondering If You Are Eligible?
Schedule a Initial Tixel Evaluation appointment at Cannon EyeCare in Pike Place Market for an eligibility evaluation. This hour-long dry eye evaluation will include imaging of your cornea and meibomian glands. Insurance billing may apply. If we are not in network the initial evaluation costs $245.
Patients already under the care of Dr. Mark Cannon for dry eye may be able to skip the screening if they have been seen this year.
Why You Should Consider Joining the Study
- Receive access to a cutting-edge Dry Eye Treatment at a reduced cost
- Help gather valuable data that supports ongoing improvements in eye care
- Work directly with Dr. Mark Cannon, a trusted Seattle dry eye specialist
- Note: as of 9/30/25 all study slots have filled
Simple, Long-Lasting Relief
Simple.
- Treatment takes only 2-3 minutes for upper and lower eyelids (both eyes)
- Rejuvenates your meibomian glands and eyelids
- No radiation, lid squeezing, or intense lights
- Comfortable treatment of outer lids/ the device does not touch the eye
- No anesthesia or ultrasound gel required
Relief.
- No downtime / return to normal activities immediately after treatment
- Effective / patients report significant reduction in symptoms
- Patients report dry eye becomes so well controlled that they need less at-home care
- The extended study showed no reduction in efficacy over 6 months
What to Expect
If eligible, you will:
- Receive three Tixel i treatments over the course of one month
- Complete a short comfort survey after each session
- Return for follow-up visits 1 and 3 months after your 3rd treatment. We would like all patients to see us 6 and 12 months after treatments ends too.
- Have your symptoms and eye health tracked before and after treatment by one of Seattle’s preeminent dry eye specialists
- All data is anonymous and follows HIPAA guidelines. This is an observational study, so your care decisions remain entirely between you and your doctor.
Schedule Your Evaluation
Only 20-25 patients will be enrolled. All treatments will be at our Pike Place, Seattle office. If you’re interested in participating, we encourage you to book an Initial Tixel Evaluation with Dr. Mark Cannon today.
If you need to call our office to book, please ask for a Tixel Evaluation appointment: (206)448-7739